Retina/Vitreous

Top Story

OCT-Leakage maps identify location of retinal, subretinal fluid

June 27, 2017

In a prospective cohort series, OCT-Leakage maps were able to identify the location and amount of retinal and subretinal fluid in eyes with a variety of retinal diseases.

Researchers analyzed 12 eyes with retinal edema from various retinal diseases. These eyes were compared with 41 eyes of 24 healthy controls.

Meeting NewsVideo

VIDEO: Preliminary study of Ozurdex for CME, proliferative retinopathy encouraging

June 26, 2017
BALTIMORE At the Association for Research in Vision and Ophthalmology meeting here, Angelo Minnella, MD, of Catholic University of the Sacred Heart in Rome…
In the Journals

Ziv-aflibercept improves visual acuity, macular thickness in refractory DME

June 23, 2017
Patients with refractory diabetic macular edema treated with ziv-aflibercept experienced improved visual acuity and macular thickness, with no adverse ocular or systemic…
Publication Exclusive

PUBLICATION EXCLUSIVE: Young woman who went blind in one eye presents years later with symptoms in fellow eye

June 22, 2017
A 21-year-old Hispanic woman presented to the University of New Mexico with a 1-month history of worsening flashes of light and scotomas in her left superior field of…
Clinical Science

Revisiting Autologous Platelets as an Adjuvant in Macular Hole Repair: Chronic Macular Holes Without Prone Positioning

Ophthalmic Surgery, Lasers and Imaging Retina, July 2012, Volume 43 Issue 4
Chronic macular hole and inability to maintain prone positioning remain poor prognostic markers for successful macular…
More »
COPE

Diabetic Eye Disease - Volume 2, Number 1

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Diabetic retinopathy (DR) is a major cause of blindness among American adults aged 40 years and older. The prevalence…
More »
Resource Centers
Video
Meeting News

Intravitreal implant with brimonidine reduced GA lesion growth in phase 2 study

May 9, 2017
More »
In the Journals

OCT-Leakage maps identify location of retinal, subretinal fluid

June 27, 2017
In a prospective cohort series, OCT-Leakage maps were able to identify the location and amount of retinal and subretinal fluid in eyes with a variety…

Meeting NewsVideo

VIDEO: Preliminary study of Ozurdex for CME, proliferative retinopathy encouraging

June 26, 2017
BALTIMORE At the Association for Research in Vision and Ophthalmology meeting here, Angelo Minnella, MD, of Catholic University of the Sacred…

In the Journals

Ziv-aflibercept improves visual acuity, macular thickness in refractory DME

June 23, 2017
Patients with refractory diabetic macular edema treated with ziv-aflibercept experienced improved visual acuity and macular thickness, with no…

Publication Exclusive

PUBLICATION EXCLUSIVE: Young woman who went blind in one eye presents years later with symptoms in fellow eye

June 22, 2017
A 21-year-old Hispanic woman presented to the University of New Mexico with a 1-month history of worsening flashes of light and scotomas in her left…

Marketing authorization application filed in Europe for Durasert 3-year uveitis treatment

June 22, 2017
A marketing authorization application has been filed to the European Medicines Agency for the approval to market Durasert 3-year treatment for…

In the Journals

Lampalizumab reduces geographic atrophy lesion progression

June 21, 2017
Monthly lampalizumab, a potential therapy for patients with geographic atrophy secondary to age-related macular degeneration, reduced lesion area…

Meeting NewsVideo

VIDEO: Brimonidine investigated for preserving vision in glaucoma and retina disease

June 21, 2017
BALTIMORE — At the Association for Research in Vision and Ophthalmology meeting here, James Burke, PhD, of Allergan, discusses research into…

Neurotech’s macular telangiectasia treatment sees positive phase 2 results

June 20, 2017
A phase 2 trial of NT-501 found the therapy had a beneficial effect in patients with macular telangiectasia type 2, according to a press release from…

Perspective

Novartis’ RTH258 for wet AMD meets endpoints in phase 3 trials

June 20, 2017
RTH258 for wet age-related macular degeneration met its primary and key secondary endpoints in two phase 3 studies, according to a Novartis press…

FDA approves ReNeuron’s cryopreserved formulation of retinal stem cell therapy candidate

June 20, 2017
The FDA has approved the cryopreserved formulation of ReNeuron Group’s human retinal progenitor cell therapeutic candidate, according to a…

More Headlines »
Advertisement
Advertisement